(Q37587678)

21 August 2017

1 reference

title

Considerations in the treatment of spasticity with intrathecal baclofen (English)

1 reference

21 August 2017

1 reference

Tamira Mullarkey

1

1 reference

21 August 2017

publication date

1 September 2009

1 reference

American Journal of Health-System Pharmacy

21 August 2017

published in

1 reference

21 August 2017

volume

66

1 reference

21 August 2017

issue

17 Suppl 5

1 reference

21 August 2017

page(s)

S14-22

1 reference

Management of spasticity.

21 August 2017

cites work

1 reference

Pathophysiology of spasticity.

31 March 2020

1 reference

A benefit-risk assessment of baclofen in severe spinal spasticity.

31 March 2020

1 reference

Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study

31 March 2020

1 reference

Update on tizanidine for muscle spasticity and emerging indications

31 March 2020

1 reference

Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke

31 March 2020

1 reference

Bedtime diazepam enhances well-being in children with spastic cerebral palsy

31 March 2020

1 reference

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

31 March 2020

1 reference

Long-term intrathecal baclofen therapy in ambulatory patients with spasticity

31 March 2020

1 reference

Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication

31 March 2020

1 reference

Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin

31 March 2020

1 reference

Density of intrathecal agents.

31 March 2020

1 reference

Intrathecal baclofen and catheter tip inflammatory mass lesions (granulomas): a reevaluation of case reports and imaging findings in light of experimental, clinicopathological, and radiological evidence

31 March 2020

1 reference

Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure: a case report

31 March 2020

1 reference

Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement

31 March 2020

1 reference

Intrathecal baclofen withdrawal: a case report and review of the literature.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.2146/AJHP0108C

1 reference

21 August 2017

1 reference